| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/30/2006 | CA2511200A1 Methods for increasing learning and memory in amyloid-beta-related neurodegenerative disorders by increasing uch-l1 activity and methods for identifying enhancers of uch-l1 activity |
| 12/28/2006 | WO2006138696A2 Genemap of the human genes associated with longevity |
| 12/28/2006 | WO2006138646A2 Protein profile for osteoarthritis |
| 12/28/2006 | WO2006138561A2 Gene expression profiling for identification and monitoring of multiple sclerosis |
| 12/28/2006 | WO2006138487A2 Treatment of ischemia-induced arrhythmias |
| 12/28/2006 | WO2006138481A2 Detection of hiv-1 infection |
| 12/28/2006 | WO2006138445A2 Methods and substrates for conducting assays |
| 12/28/2006 | WO2006138444A2 Lysis and stabilization buffer suitable for inclusion in pcr reactions |
| 12/28/2006 | WO2006138443A2 Normalization of samples for amplification reactions |
| 12/28/2006 | WO2006138377A2 Compound combinations for inhibiting cell division and methods for their identification and use |
| 12/28/2006 | WO2006138284A2 Nucleic acid analysis by random mixtures of non-overlapping fragments |
| 12/28/2006 | WO2006138257A2 Single molecule arrays for genetic and chemical analysis |
| 12/28/2006 | WO2006138225A2 A novel and practical serological assay for the clinical diagnosis of leishmaniasis |
| 12/28/2006 | WO2006138183A2 Multiplexed polymerase chain reaction for genetic sequence analysis |
| 12/28/2006 | WO2006138182A2 Computer-implemented biological sequence identifier system and method |
| 12/28/2006 | WO2006138038A1 Intralesional treatment of psoriasis |
| 12/28/2006 | WO2006138012A1 P450 substrates and methods related thereto |
| 12/28/2006 | WO2006137939A2 Compositions and methods for detecting group a streptococci |
| 12/28/2006 | WO2006137830A2 Detection of mycobacterium |
| 12/28/2006 | WO2006137734A1 Improved strategies for sequencing complex genomes using high throughput sequencing technologies |
| 12/28/2006 | WO2006137733A1 Strategies for high throughput identification and detection of polymorphisms |
| 12/28/2006 | WO2006137611A1 Dna nucleotide sequence from sweetpotato for targeting on chloroplast |
| 12/28/2006 | WO2006137597A1 Novel physiological substance nesfatin, substance relevant thereto, and use of the substances |
| 12/28/2006 | WO2006137595A1 Prophylactic/therapeutic agent for her2-expressing cancer |
| 12/28/2006 | WO2006137551A2 Diagnostic method for cancer and diagnostic method for lung cancer |
| 12/28/2006 | WO2006137550A2 Diagnostic method for cancer and diagnostic method for lung cancer |
| 12/28/2006 | WO2006137487A1 GENE POLYMORPHISMS USEFUL IN ANTICIPATING RESPONSES TO β-BLOCKER DRUGS |
| 12/28/2006 | WO2006137444A1 Method of eliminating reactivity from lipoarabinomannan and application of the same |
| 12/28/2006 | WO2006137435A1 Agonist to g protein-coupled receptor g2a and method of screening g2a activity controller |
| 12/28/2006 | WO2006137283A1 Mutant glucose dehydrogenase |
| 12/28/2006 | WO2006137190A1 Photofunctional nucleic acid, method of producing the same and method of determining methylation |
| 12/28/2006 | WO2006137085A1 Genetic variants in the tcf7l2 gene as diagnostic markers for risk of type 2 diabetes mellitus |
| 12/28/2006 | WO2006137066A2 Diagnosing pathological conditions using interallelic epigentic variations |
| 12/28/2006 | WO2006136841A1 Multiple sclerosis therapy and diagnosis |
| 12/28/2006 | WO2006136791A1 Polymorphisms and haplotypes in p2x7 gene and their use in determining susceptibility for atherosclerosis-mediated diseases |
| 12/28/2006 | WO2006136698A2 Method for determining a pathogenic contamination in a blood platelet-containing fluid |
| 12/28/2006 | WO2006136686A1 Method for fixing a supercoiled dna and the use for analysing the dna repair |
| 12/28/2006 | WO2006136640A1 Detection and identification of bacteriophages of lactic acid bacteria by means of multiple polymerase chain reaction (multi-pcr) and applications thereof |
| 12/28/2006 | WO2006136639A1 Method and kit for the detection of bacterial species by means of dna analysis |
| 12/28/2006 | WO2006136621A1 Nucleic acid detection method involving the direct generation of a measurable signal |
| 12/28/2006 | WO2006136392A2 Novel genes and proteins of brachyspira pilosicoli and use of same for diagnosis and therapy |
| 12/28/2006 | WO2006136170A2 Disease risk estimating method using sequence polymorphisms in a specific region of chromosome 19 |
| 12/28/2006 | WO2006136033A1 Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy |
| 12/28/2006 | WO2006136006A1 Lgi, lingo and p75ntr family members: novel modulators of neuronal growth |
| 12/28/2006 | WO2006135992A1 Method and means for detecting and/or quantifying hierarchical molecular change of a cell in response to an external stimulus |
| 12/28/2006 | WO2006121703A3 Mapping new sites for antibiotic action in the ribosome |
| 12/28/2006 | WO2006106340A8 Formation of aggregates in enzyme assays |
| 12/28/2006 | WO2006097462A3 Compositions and methods for treating inflammatory cns disorders |
| 12/28/2006 | WO2006097339A9 Method and materials therefor |
| 12/28/2006 | WO2006089911A3 Expression cassettes for seed-preferential expression in plants |
| 12/28/2006 | WO2006088950A3 Methods and reagents for treatment and diagnosis of age-related macular degeneration |
| 12/28/2006 | WO2006040549B1 Labelling and sequencing of nucleic acids |
| 12/28/2006 | WO2006009947A3 Migfs as modifiers of the igf pathway and methods of use |
| 12/28/2006 | WO2006004936A3 Analysis of intracellular modifications |
| 12/28/2006 | WO2006003518A3 6-phosphorylcholine-n-acetyl-d-galactosamine conjugate molecules and their use in vaccinal, therapeutic and diagnostic applications against bacterial infection of the respiratory tract |
| 12/28/2006 | WO2005121367A8 Diagnostic primers and method for detecting avian influenza virus subtype h5 and h5n1 |
| 12/28/2006 | WO2005111241A8 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof |
| 12/28/2006 | WO2005110489A3 Nucleic acid aptamers conjugated to high molecular weight steric groups |
| 12/28/2006 | WO2005089409A3 Sensor constructs and detection methods |
| 12/28/2006 | WO2005080587A3 Glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase c regulation |
| 12/28/2006 | WO2005072049A3 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosis |
| 12/28/2006 | WO2005045025A3 Cloning and characterization of 5’ flanking regions of a human aggrecanase-1 gene |
| 12/28/2006 | WO2005042701A3 Methods to identify compounds useful for tumor sensitization to dna damage |
| 12/28/2006 | WO2005036133A3 Electrode-based detection of polynucleotides |
| 12/28/2006 | WO2004041067A3 Prevention and treatment of synucleinopathic disease |
| 12/28/2006 | WO2004038372A3 Cdkl1 as modifier of branching morphogenesis and methods of use |
| 12/28/2006 | WO2003014295A9 Method and system for identifying splice variants of a gene |
| 12/28/2006 | US20060294622 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 12/28/2006 | US20060294620 use of amylases of the invention in starch conversion processes, including production of high fructose corn syrup (HFCS), ethanol, dextrose, and dextrose syrups; polypeptides having thermostable amylase activity |
| 12/28/2006 | US20060294615 Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer |
| 12/28/2006 | US20060294614 Orphan receptors; drug screening; host cells |
| 12/28/2006 | US20060294612 Gpcr-like retinoic acid-induced gene 1 protein and nucleic acid |
| 12/28/2006 | US20060294607 Human podocalyxin alternative-spliced forms and uses thereof |
| 12/28/2006 | US20060294605 Novel human dickkopf-related protein and nucleic acid molecules and uses therefor |
| 12/28/2006 | US20060294604 Model for studying the role of genes in tumor resistance to chemotherapy |
| 12/28/2006 | US20060294601 Compositions, organisms and methodologies employing a novel human kinase |
| 12/28/2006 | US20060294600 Modulation of osteoblast activity by fhl2 |
| 12/28/2006 | US20060293267 Dual functional oligonucleotides for use as anti-viral agents |
| 12/28/2006 | US20060293256 Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 12/28/2006 | US20060293239 Treatment and Diagnosis of Insulin-Resistant States |
| 12/28/2006 | US20060292693 comprises a heavy chain variable region and a light chain variable region produced by mouse hybridoma cell line 1G3; capable of neutralizing EV71 infection |
| 12/28/2006 | US20060292687 Methods for modulating floral organ identity, modulating floral organ number, increasing of meristem size, and delaying flowering time |
| 12/28/2006 | US20060292678 Gluconobacter oxydans 2-ketoreductase enzyme and applications thereof |
| 12/28/2006 | US20060292673 For degradation of glycosaminoglycans; inhibiting angiogenesis and cellular proliferation; treating cancer, neurodegenerative disease, atherosclerosis and microbial infection |
| 12/28/2006 | US20060292668 Nuclear factor of activated t cell receptor |
| 12/28/2006 | US20060292664 Using lanthanide ions to complex with and illuminate bacterial polypeptide on surface; sterility testing |
| 12/28/2006 | US20060292663 Method of measuring lactate dehydrogenase activity in serum, and device for measuring lactate dehydrogenase activity in serum |
| 12/28/2006 | US20060292662 Galleria mellonella derived composition for detecting peptidoglycan, a method for use thereof, and a diagnostic kit containing the same |
| 12/28/2006 | US20060292661 Electrochemical sensing assays involving drug metabolizing enzymes |
| 12/28/2006 | US20060292660 Drug screening; administering albumin attached to alcohol, organic acid, saccharide or amino acid and determining amount administered to the subject or degradation product or metabolite that migrated into the blood and/or is excreted out of the body |
| 12/28/2006 | US20060292659 Binding a polypeptide having an anchor region and a protease recognition site to a solid support comprising a protein via a protein-protein interaction; industrial scale drug screening for hepatitis C protease inhibitors; high speed |
| 12/28/2006 | US20060292658 Fluorescent compound |
| 12/28/2006 | US20060292657 Phex substrates and methods using same |
| 12/28/2006 | US20060292656 Lactamase amplification substrate |
| 12/28/2006 | US20060292655 2-O sulfatase compositions and methods of analyzing therewith |
| 12/28/2006 | US20060292654 Microwell plate |
| 12/28/2006 | US20060292653 Metal mediated fluorescence superquenching assays for detection of phosphorylation and dephosphorylation of quencher-labeled substrates |
| 12/28/2006 | US20060292652 Substrate detection assay |
| 12/28/2006 | US20060292651 Protein labelling with oº-alkylguanine-dna alkyltrnsferase |
| 12/28/2006 | US20060292650 Spectroscopic analysis of a biological fluid reacted with an enzyme |